Q3 2022 Holdings
Filed 2022-11-14 | 69 holdings | $1.2B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $208.9M | 781,700 | 18.1% |
| Biohaven Pharmactl Hldg Co L(BHVN)A | COM | G11196105 | $96.3M | 637,139 | 8.4% |
| GSK PLC(GSK)A | SPONSORED AD | 37733W204 | $87.3M | 2,939,070 | 7.6% |
| Horizon Therapeutics PUB LA | SHS | G46188101 | $78.6M | 1,269,591 | 6.8% |
| Natera Inc(NTRA)A | COM | 632307104 | $62.5M | 1,425,602 | 5.4% |
| GSK PLC(GSK)CallA | SPONSORED AD | 37733W204 | $61.6M | 2,093,700 | 5.3% |
| United Therapeutics Corp del(UTHR)A | COM | 91307C102 | $53.4M | 255,226 | 4.6% |
| Danaher Corporation(DHR)A | COM | 235851102 | $42.0M | 162,546 | 3.6% |
| Sanofi(SNY)A | SPONSORED ADR | 80105N105 | $37.9M | 996,035 | 3.3% |
| Teva Pharmaceutical Inds LTD(TEVA)A | SPONSORED ADS | 881624209 | $32.8M | 4,062,935 | 2.8% |
| Syndax Pharmaceuticals Inc(SNDX)A | COM | 87164F105 | $29.1M | 1,211,434 | 2.5% |
| Envista Holdings Corporation(NVST)A | COM | 29415F104 | $20.8M | 633,001 | 1.8% |
| Illumina Inc(ILMN)A | COM | 452327109 | $20.4M | 107,002 | 1.8% |
| Community Health SYS Inc New(CYH)A | COM | 203668108 | $19.0M | 8,841,604 | 1.6% |
| Celldex Therapeutics Inc New(CLDX)A | COM NEW | 15117B202 | $17.6M | 626,372 | 1.5% |
| Biogen Inc(BIIB)A | COM | 09062X103 | $16.1M | 60,144 | 1.4% |
| Elevance Health Inc(ELV)A | COM | 036752103 | $15.0M | 33,040 | 1.3% |
| Centene Corp del(CNC)A | COM | 15135B101 | $14.9M | 191,308 | 1.3% |
| Lantheus Hldgs Inc(LNTH)A | COM | 516544103 | $14.6M | 206,893 | 1.3% |
| Biogen Inc(BIIB)PutA | COM | 09062X103 | $13.4M | 50,000 | 1.2% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $13.0M | 11,962,744 | 1.1% |
| Abiomed Inc(ABMDEUR)A | COM | 003654100 | $13.0M | 52,970 | 1.1% |
| Seres Therapeutics Inc(MCRB1EUR)A | COM | 81750R102 | $12.4M | 1,935,825 | 1.1% |
| Humana Inc(HUM)A | COM | 444859102 | $11.9M | 24,572 | 1.0% |
| Biogen Inc(BIIB)CallA | COM | 09062X103 | $9.9M | 37,100 | 0.9% |
| Viridian Therapeutics Inc(VRDN)A | COM | 92790C104 | $9.8M | 478,387 | 0.9% |
| Amneal Pharmaceuticals Inc(AMRX)A | COM STK CL A | 03168L105 | $9.5M | 4,690,812 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE)A | COM | 98420N105 | $9.4M | 259,612 | 0.8% |
| Guardant Health Inc(GH)A | COM | 40131M109 | $9.2M | 171,481 | 0.8% |
| Ionis Pharmaceuticals Inc(IONS)A | COM | 462222100 | $8.9M | 201,833 | 0.8% |
| Spdr SER TR(XBI)A | S&P BIOTECH | 78464A870 | $7.9M | 100,000 | 0.7% |
| Liquidia Corporation(LQDA)A | COM NEW | 53635D202 | $7.6M | 1,401,443 | 0.7% |
| Spdr SER TR(XBI)CallA | S&P BIOTECH | 78464A870 | $7.1M | 90,000 | 0.6% |
| Taro Pharmaceutical Inds LTDA | SHS | M8737E108 | $6.7M | 223,383 | 0.6% |
| Gossamer BIO Inc(GOSS)A | COM | 38341P102 | $6.6M | 548,431 | 0.6% |
| Pliant Therapeutics Inc(PLRX)A | COM | 729139105 | $6.1M | 294,103 | 0.5% |
| Merus N VA | COM | N5749R100 | $5.5M | 276,673 | 0.5% |
| Merck & Co Inc(MRK)CallA | COM | 58933Y105 | $4.2M | 48,700 | 0.4% |
| Maravai Lifesciences Hldgs I(MRVI)A | COM CL A | 56600D107 | $4.1M | 160,000 | 0.4% |
| Affimed N VA | COM | N01045108 | $3.9M | 1,887,999 | 0.3% |
| Aerie Pharmaceuticals Inc(AERIEUR)A | COM | 00771V108 | $3.9M | 256,289 | 0.3% |
| Puma Biotechnology Inc(PBYI)A | COM | 74587V107 | $3.6M | 1,505,705 | 0.3% |
| Vera Therapeutics Inc(VERA)A | CL A | 92337R101 | $3.3M | 156,129 | 0.3% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $3.2M | 141,558 | 0.3% |
| Point Biopharma Global IncA | COM | 730541109 | $3.2M | 410,052 | 0.3% |
| Agilent Technologies Inc(A)A | COM | 00846U101 | $2.6M | 21,521 | 0.2% |
| Teva Pharmaceutical Inds LTD(TEVA)CallA | SPONSORED ADS | 881624209 | $2.2M | 272,900 | 0.2% |
| 908 Devices Inc(MASS)A | COM | 65443P102 | $2.2M | 130,768 | 0.2% |
| AMN Healthcare Svcs Inc(AMN)PutA | COM | 001744101 | $2.0M | 19,000 | 0.2% |
| Icon PLC(ICLR)A | SHS | G4705A100 | $1.9M | 10,212 | 0.2% |